Back to search results

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

Abroad (travel likely)Recruiting

Conditions

Leukemia · Myelodysplastic Syndromes · Myeloproliferative Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Connecticut Children's Medical Center, Hartford, Connecticut, United States

    Contact: Study coordinator (Natalie Bezler, MD) · Nbezler@connecticutchildrens.org

  • Maine Medical Center, Portland, Maine, United States

    Contact: Study coordinator (Sei Sze, MD) · Sei.Sze@mainehealth.org

  • Boston Children's Hospital, Boston, Massachusetts, United States

  • Dana Farber Cancer Institute, Boston, Massachusetts, United States

  • Dartmouth-Hitchcock, Lebanon, New Hampshire, United States

    Contact: Study coordinator (Angela Ricci, MD) · angela.m.ricci@hitchcock.org

  • Albany Medical Center, Albany, New York, United States

    Contact: Study coordinator (Jessica Geaney, MD) · geaneyj@amc.edu

  • Lifespan Cancer Institute, Providence, Rhode Island, United States

    Contact: Study coordinator (Jennifer Welch, MD) · jwelch@lifespan.org

  • University of Vermont Medical Center, Burlington, Vermont, United States

    Contact: Study coordinator (Jessica Heath, MD) · Jessica.Heath@uvmhealth.org
Study leads

  • Yana Pikman, MD

    Principal Investigator

    Dana-Farber Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)